Methyl 3-amino-4-(cyclopropylamino)benzoate, 95.0%, 5g

Fmoc-D-Thr(PO(OBzl)OH)-OH, 97%, 5g

2-Cyano-N-m-tolyl-acetamide, 5g

(R)-2-(4-Fluorophenyl)pyrrolidine hydrochloride, 95.0%, 5g

5-THIOPHEN-2-YL-ISOXAZOLE, 95%, 1g

cis-5-Norbornene-endo-2,3-dicarboxylic Acid>98.0%(GC)(T)5g

cis-Diammineplatinum(II) Dichloride100mg

4-Methyl-2-nitro-N-(4-(N-(thiazol-2-yl)sulfamoyl)phenyl)benzenesulfonamide, 97%, 1g

2',7'-Dibromospiro[fluorene-9,9'-xanthene], 97%, 5g

3-Fluoro-2-pyridinecarboxaldehyde, 95.0%, 1g

N-Cyclopropyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 96%, 1g

Plan PLPH 10x/0.25 phase contrast objective

Iron foil 99.99+% 1.0 x 25 x 25 mm 1 pc